Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

AstraZeneca plc (ADR) Company Profile (NYSE:AZN)

Consensus Ratings for AstraZeneca plc (ADR) (NYSE:AZN) (?)
Ratings Breakdown: 4 Sell Rating(s), 10 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $67.00 (3.39% downside)

Current Analysts' Coverage Summary for AstraZeneca plc (ADR) (NYSE:AZN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/16/2014Deutsche BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
10/16/2014Credit SuisseReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
10/14/2014Bank of AmericaUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/13/2014Jefferies GroupUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
10/7/2014Panmure GordonUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
9/29/2014JPMorgan Chase & Co.Reiterated RatingUnderweightViewTweet This Rating  Share This Rating on StockTwits
9/29/2014Beaufort SecuritiesReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
9/15/2014ZacksReiterated RatingNeutral -> Neutral$77.00ViewTweet This Rating  Share This Rating on StockTwits
8/4/2014BarclaysReiterated RatingEqual WeightViewTweet This Rating  Share This Rating on StockTwits
7/31/2014Berenberg BankReiterated RatingHoldViewTweet This Rating  Share This Rating on StockTwits
7/16/2014Citigroup Inc.Reiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
7/9/2014Liberum CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
6/5/2014BNP ParibasReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Kepler Capital MarketsDowngradeHold -> ReduceViewTweet This Rating  Share This Rating on StockTwits
5/27/2014Societe GeneraleDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
5/20/2014DanskeUpgradeHoldViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Prime WealthReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Leerink SwannDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/13/2014Morgan StanleyDowngradeUnderweightViewTweet This Rating  Share This Rating on StockTwits
2/26/2014Galvan ResearchReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
12/20/2013Bryan Garnier & CieDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
12/20/2013NatixisBoost Price Target$53.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
9/16/2013Nordea Equity ResearchUpgradeSell -> BuyViewTweet This Rating  Share This Rating on StockTwits
4/29/2013Goldman SachsReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
4/26/2013Sanford C. BernsteinLower Price TargetMarket Perform$54.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
10/26/2012Pareto SecuritiesDowngradeSell -> Hold$44.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
10/26/2012SwedbankDowngradeNeutral -> ReduceViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/24/2012 forward)
Discuss AstraZeneca plc (ADR)